Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,582 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combination of gemcitabine and carboplatin as first line treatment in elderly patients or those unfit for cisplatin-based chemotherapy with advanced transitional cell carcinoma of the urinary tract.
Park JH, Lee SW, Kim HS, Kang SG, Ko YH, Kim ST, Kang SH, Park YJ, Choi IK, Oh SC, Sung DJ, Seo JH, Cheon J, Kim YH, Kim JS, Park KH. Park JH, et al. Among authors: park yj, park kh. Cancer Chemother Pharmacol. 2013 Apr;71(4):1033-9. doi: 10.1007/s00280-013-2098-9. Epub 2013 Feb 1. Cancer Chemother Pharmacol. 2013. PMID: 23370665
Modified MVAC as a Second-Line Treatment for Patients with Metastatic Urothelial Carcinoma after Failure of Gemcitabine and Cisplatin Treatment.
Lee JH, Kang SG, Kim ST, Kang SH, Choi IK, Park YJ, Oh SC, Sung DJ, Seo JH, Cheon J, Shin SW, Kim YH, Kim JS, Park KH. Lee JH, et al. Among authors: park yj, park kh. Cancer Res Treat. 2014 Apr;46(2):172-7. doi: 10.4143/crt.2014.46.2.172. Epub 2014 Apr 22. Cancer Res Treat. 2014. PMID: 24851109 Free PMC article.
BioPATH: A Biomarker Study in Asian Patients with HER2+ Advanced Breast Cancer Treated with Lapatinib and Other Anti-HER2 Therapy.
Kim SB, Do IG, Tsang J, Kim TY, Yap YS, Cornelio G, Gong G, Paik S, Lee S, Ng TY, Park S, Oh HS, Chiu J, Sohn J, Lee M, Choi YJ, Lee EM, Park KH, Nathaniel C, Ro J. Kim SB, et al. Among authors: park kh, park s. Cancer Res Treat. 2019 Oct;51(4):1527-1539. doi: 10.4143/crt.2018.598. Epub 2019 Jun 4. Cancer Res Treat. 2019. PMID: 31163957 Free PMC article.
Clinical Implication of Concordant or Discordant Genomic Profiling between Primary and Matched Metastatic Tissues in Patients with Colorectal Cancer.
Choi JY, Choi S, Lee M, Park YS, Sung JS, Chang WJ, Kim JW, Choi YJ, Kim J, Kim DS, Lee SH, Seok J, Park KH, Kim SH, Kim YH. Choi JY, et al. Among authors: park kh, park ys. Cancer Res Treat. 2020 Jul;52(3):764-778. doi: 10.4143/crt.2020.044. Epub 2020 Feb 16. Cancer Res Treat. 2020. PMID: 32065847 Free PMC article.
4,582 results